-
公开(公告)号：US20180303861A1
公开(公告)日：2018-10-25
申请号：US15959532
申请日：2018-04-23
申请人： Eric Marcotulli , Dan Alminana , Ryan Dellinger , Mark Morris
发明人： Eric Marcotulli , Dan Alminana , Ryan Dellinger , Mark Morris
IPC分类号： A61K31/706 , A61K31/09 , A61P13/12
CPC分类号： A61K31/706 , A61K31/09 , A61P13/12
摘要： Provided herein are methods and compositions related to treating and/or preventing kidney related diseases and disorders, treating and/or preventing acute kidney injury, and for improving kidney health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
-
2.发明申请METHOD FOR INDUCING UDP-GLUCURONOSYLTRANSFERASE ACTIVITY USING PTEROSTILBENE 有权用吡喹酮诱导UDP-葡萄糖醛缩酶活性的方法公开(公告)号：US20120289605A1
公开(公告)日：2012-11-15
申请号：US13466827
申请日：2012-05-08
申请人： Jeremy Bartos , Ryan Dellinger
发明人： Jeremy Bartos , Ryan Dellinger
CPC分类号： A61K31/09
摘要： A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene.
摘要翻译： 提供了一种用于治疗个体细胞增殖性疾病的方法，包括向需要这种治疗的个体施用治疗有效量的其中UDP-葡糖醛酸基转移酶（UGT）活性增加的化合物ter芪烯。 在一个实施方案中，可以通过施用蝶啶二苯乙烯来降低12-HETE水平。
-
3.发明授权Method for inducing UDP-glucuronosyltransferase activity using pterostilbene 有权使用ter il for诱导UDP-葡糖醛酸基转移酶活性的方法公开(公告)号：US08841350B2
公开(公告)日：2014-09-23
申请号：US13466827
申请日：2012-05-08
申请人： Jeremy Bartos , Ryan Dellinger
发明人： Jeremy Bartos , Ryan Dellinger
IPC分类号： A61K31/09
CPC分类号： A61K31/09
摘要： A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene.
摘要翻译： 提供了一种用于治疗个体细胞增殖性疾病的方法，包括向需要这种治疗的个体施用治疗有效量的其中UDP-葡糖醛酸基转移酶（UGT）活性增加的化合物ter芪烯。 在一个实施方案中，可以通过施用蝶啶二苯乙烯来降低12-HETE水平。
-
-
搜索结果
3 条记录 (耗时 0.013 秒)
